EKS-MUM-00314
Eukaryotic Protein Kinase & Protein Phosphatase Database
TagContent
EKPD IDEKS-MUM-00314
Classification
Group/FamilyScoreE-ValueStartEndDomain Length
TKL/STKR408.43.9E-122206493288
StatusReviewed
Ensembl ProteinENSMUSP00000035093
UniProt AccessionP27040; Q3KQI1;
Protein NameActivin receptor type-2B
Protein Synonyms/Alias Activin receptor type IIB; ACTR-IIB;
Gene NameAcvr2b
Gene Synonyms/Alias Acvr2b;
Ensembl Information
Ensembl Gene IDEnsembl Protein IDEnsembl Transcript ID
ENSMUSG00000061393ENSMUSP00000126108ENSMUST00000165044
ENSMUSG00000061393ENSMUSP00000035093ENSMUST00000035093
OrganismMus musculus
Functional DescriptionTransmembrane serine/threonine kinase activin type-2receptor forming an activin receptor complex with activin type-1 serine/threonine kinase receptors (ACVR1, ACVR1B or ACVR1c). Transduces the activin signal from the cell surface to the cytoplasm and is thus regulating many physiological and pathological processes including neuronal differentiation and neuronal survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in follicular development in the ovary. Within the receptor complex, the type-2 receptors act as a primary activin receptors (binds activin-A/INHBA, activin-B/INHBB as well as inhibin-A/INHA-INHBA). The type-1 receptors like ACVR1B act as downstream transducers of activin signals. Activin binds to type-2 receptor at the plasma membrane and activates its serine-threonine kinase. The activated receptor type-2 then phosphorylates and activates the type-1 receptor. Once activated, the type-1 receptor binds and phosphorylates the SMAD proteins SMAD2 and SMAD3, on serine residues of the C-terminal tail. Soon after their association with the activin receptor and subsequent phosphorylation, SMAD2 and SMAD3 are released into the cytoplasm where they interact with the common partner SMAD4. This SMAD complex translocates into the nucleus where it mediates activin-induced transcription. Inhibitory SMAD7, which is recruited to ACVR1B through FKBP1A, can prevent the association of SMAD2 and SMAD3 with the activin receptor complex, thereby blocking the activin signal. Activin signal transduction is also antagonized by the binding to the receptor of inhibin-B via the IGSF1 inhibin coreceptor (By similarity).
Protein Length528
Protein Sequence
(FASTA)
MTAPWAALAL LWGSLCAGSG RGEAETRECI YYNANWELER TNQSGLERCE GEQDKRLHCY 60
ASWRNSSGTI ELVKKGCWLD DFNCYDRQEC VATEENPQVY FCCCEGNFCN ERFTHLPEPG 120
GPEAPTLLTV LAYSLLPIGG LSLIVLLAFW MYRHRKPPYG HVDIHEVRQC QRWAGRRDGC 180
ADSFKPLPFQ DPGPPPPSPL VGLKPLQLLE IKARGRFGCV WKAQLMNDFV AVKIFPLQDK 240
QSWQSEREIF STPGMKHENL LQFIAAEKRG SNLEVELWLI TAFHDKGSLT DYLKGNIITW 300
NELCHVAETM SRGLSYLHED VPWCRGEGHK PSIAHRDFKS KNVLLKSDLT AVLADFGLAV 360
RFEPGKPPGD THGQVGTRRY MAPEVLEGAI NFQRDAFLRI DMYAMGLVLW ELVSRCKAAD 420
GPVDEYMLPF EEEIGQHPSL EELQEVVVHK KMRPTIKDHW LKHPGLAQLC VTIEECWDHD 480
AEARLSAGCV EERVSLIRRS VNGTTSDCLV SLVTSVTNVD LLPKESSI 528
Nucleotide Sequence
(FASTA)
ATGACGGCGC CCTGGGCGGC CCTCGCCCTT CTCTGGGGAT CGCTGTGCGC CGGTTCCGGG 60
CGAGGGGAGG CTGAGACTCG GGAGTGCATC TACTACAACG CCAACTGGGA GCTGGAGCGC 120
ACCAACCAGA GCGGCCTGGA GCGCTGCGAG GGGGAACAGG ACAAGCGGCT GCACTGCTAC 180
GCCTCGTGGC GCAACAGCTC GGGCACCATC GAGCTGGTGA AGAAGGGCTG CTGGCTAGAT 240
GACTTCAATT GCTACGACAG GCAGGAGTGT GTGGCCACCG AGGAGAACCC CCAGGTGTAC 300
TTCTGCTGCT GCGAAGGCAA CTTCTGCAAC GAGCGCTTCA CCCACTTGCC GGAGCCTGGG 360
GGCCCAGAAG CCCCCACCCT GCTCACGGTG CTGGCCTACT CGCTGCTGCC CATTGGAGGC 420
CTCTCTCTCA TCGTCCTGCT GGCCTTCTGG ATGTATCGTC ATCGGAAGCC TCCCTACGGC 480
CATGTGGACA TCCATGAGGT GAGACAGTGC CAGCGTTGGG CAGGGAGAAG GGACGGCTGT 540
GCGGACTCCT TTAAGCCCTT GCCTTTCCAG GACCCGGGGC CTCCGCCCCC ATCCCCTCTG 600
GTGGGCCTGA AGCCACTACA GCTGCTGGAG ATCAAGGCTC GGGGCCGCTT TGGCTGCGTT 660
TGGAAAGCTC AGCTCATGAA CGACTTTGTG GCTGTGAAGA TCTTCCCACT TCAGGACAAG 720
CAGTCGTGGC AGAGTGAACG GGAAATCTTC AGCACACCCG GCATGAAGCA CGAAAACTTG 780
TTGCAGTTCA TTGCTGCCGA GAAACGAGGC TCCAACCTGG AGGTGGAGCT GTGGCTCATC 840
ACAGCCTTCC ACGACAAGGG CTCCCTCACG GATTACCTCA AGGGGAACAT CATCACGTGG 900
AACGAACTGT GCCACGTGGC GGAGACGATG TCACGAGGCC TCTCATACCT GCATGAGGAT 960
GTGCCGTGGT GTCGTGGTGA GGGCCACAAG CCTTCTATTG CCCACAGGGA CTTCAAAAGC 1020
AAGAATGTAC TGCTGAAGAG CGACCTCACC GCGGTGCTGG CTGACTTCGG CCTGGCTGTT 1080
CGGTTTGAGC CAGGGAAGCC TCCTGGGGAT ACCCATGGAC AGGTTGGCAC CAGACGGTAC 1140
ATGGCCCCTG AGGTGCTGGA AGGAGCCATC AACTTCCAGA GAGACGCCTT CCTGCGTATC 1200
GACATGTACG CCATGGGCCT GGTGCTGTGG GAGCTCGTCT CTCGGTGCAA GGCTGCAGAC 1260
GGGCCTGTCG ATGAGTACAT GCTGCCCTTC GAGGAGGAGA TTGGCCAGCA CCCTTCGCTG 1320
GAGGAGCTTC AGGAGGTGGT TGTCCACAAG AAGATGAGGC CCACGATTAA GGATCACTGG 1380
CTGAAACACC CGGGCCTGGC CCAGCTCTGC GTGACCATCG AGGAGTGCTG GGACCATGAT 1440
GCAGAGGCTC GCCTTTCTGC AGGCTGTGTA GAAGAGCGGG TATCCCTGAT CAGGAGGTCG 1500
GTCAACGGCA CTACCTCGGA CTGTCTCGTC TCTCTGGTGA CCTCCGTCAC CAATGTGGAC 1560
CTGCTCCCTA AAGAGTCCAG CATCTAA 1587
Domain Profile
S: 1     lklleligkGrygeVwkaklrgeevAvKifstedeaswkrEkeiyqtvllrhenilqfia  60
         l+lle+ ++Gr+g+Vwka+l+++ vAvKif+ +d++sw++E+ei++t+ ++hen+lqfia
Q: 206   LQLLEIKARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIA  265
         6899********************************************************
S: 61    adkkeedsltelllvteyhekgsLsdyLkretldveellrlalslasGlahLHeeivgtk  120
         a+k+ +++++el+l+t++h+kgsL+dyLk ++++++el+++a+++++Gl++LHe++++++
Q: 266   AEKRGSNLEVELWLITAFHDKGSLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCR  325
         ************************************************************
S: 121   g.kkKpaiaHRDlkskNilvkkdltcciaDlGLalkleeekeeldlaansqvGtkRYmaP  179
         g  +Kp+iaHRD+kskN+l+k+dlt+++aD+GLa+++e  k   d  ++ qvGt+RYmaP
Q: 326   GeGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD--THGQVGTRRYMAP  383
         *99***************************************888..79***********
S: 180   EvleealnlkdfeafkraDvYslgLvlWEvasRceevdeeveeyklpfeevvgsdPslee  239
         Evle+a+n+++ +af r+D+Y++gLvlWE++sRc+++d+ v+ey+lpfee++g++Pslee
Q: 384   EVLEGAINFQR-DAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEE  442
         **********9.9***********************************************
S: 240   mkevvvekklrPkipeawkkkealkelsklleecWdadpeaRltalrvkkr  290
         ++evvv+kk+rP+i+++w k++ l++l+ ++eecWd+d+eaRl+a +v++r
Q: 443   LQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEER  493
         ************************************************998
Domain Sequence
(FASTA)
LQLLEIKARG RFGCVWKAQL MNDFVAVKIF PLQDKQSWQS EREIFSTPGM KHENLLQFIA 60
AEKRGSNLEV ELWLITAFHD KGSLTDYLKG NIITWNELCH VAETMSRGLS YLHEDVPWCR 120
GEGHKPSIAH RDFKSKNVLL KSDLTAVLAD FGLAVRFEPG KPPGDTHGQV GTRRYMAPEV 180
LEGAINFQRD AFLRIDMYAM GLVLWELVSR CKAADGPVDE YMLPFEEEIG QHPSLEELQE 240
VVVHKKMRPT IKDHWLKHPG LAQLCVTIEE CWDHDAEARL SAGCVEER 288
Keyword3D-structure; Alternative splicing; ATP-binding; Cell membrane; Complete proteome; Disulfide bond; Glycoprotein; Kinase; Magnesium; Manganese; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome; Serine/threonine-protein kinase; Signal; Transferase; Transmembrane; Transmembrane helix.
Sequence SourceEnsembl
Orthology
Ortholog group
Ailuropoda melanoleuca"; ?>Anolis carolinensis"; ?>Bos taurus"; ?>Caenorhabditis elegans"; ?>Callithrix jacchus"; ?>Canis familiaris"; ?>Cavia porcellus"; ?>Ciona intestinalis"; ?>Ciona savignyi"; ?>Danio rerio"; ?>Drosophila melanogaster"; ?>Equus caballus"; ?>Felis catus"; ?>Gadus morhua"; ?>Gallus gallus"; ?>Gasterosteus aculeatus"; ?>Gorilla gorilla"; ?>Homo sapiens"; ?>Ictidomys tridecemlineatus"; ?>Latimeria chalumnae"; ?>Loxodonta africana"; ?>Macaca mulatta"; ?>Meleagris gallopavo"; ?>Microcebus murinus"; ?>Monodelphis domestica"; ?>Mustela putorius furo"; ?>Nomascus leucogenys"; ?>Oreochromis niloticus"; ?>Oryzias latipes"; ?>Otolemur garnettii"; ?>Pan troglodytes"; ?>Pelodiscus sinensis"; ?>Petromyzon marinus"; ?>Pongo abelii"; ?>Pteropus vampyrus"; ?>Rattus norvegicus"; ?>Sarcophilus harrisii"; ?>Sus scrofa"; ?>Taeniopygia guttata"; ?>Takifugu rubripes"; ?>Tetraodon nigroviridis"; ?>Tupaia belangeri"; ?>Tursiops truncatus"; ?>Xenopus tropicalis"; ?>Xiphophorus maculatus"; ?>
EKS-AIM-00265
EKS-ANC-00271
EKS-BOT-00283
EKS-CAE-00245
EKS-CAJ-00289
EKS-CAF-00289
EKS-CAP-00318
EKS-CII-00166
EKS-CIS-00047
EKS-DAR-00628
EKS-DRM-00144
EKS-EQC-00275
EKS-FEC-00269
EKS-GAM-00177
EKS-GAG-00236
EKS-GAA-00346
EKS-GOG-00282
EKS-HOS-00289
EKS-ICT-00267
EKS-LAC-00294
EKS-LOA-00293
EKS-MAM-00285
EKS-MEG-00223
EKS-MIM-00021
EKS-MOD-00278
EKS-MUP-00278
EKS-NOL-00261
EKS-ORN-00364
EKS-ORL-00340
EKS-OTG-00288
EKS-PAT-00267
EKS-PES-00252
EKS-PEM-00152
EKS-POA-00274
EKS-PTV-00040
EKS-RAN-00299
EKS-SAH-00265
EKS-SUS-00249
EKS-TAG-00294
EKS-TAR-00366
EKS-TEN-00367
EKS-TUB-00024
EKS-TUT-00041
EKS-XET-00357
EKS-XIM-00357
Gene Ontology
GO:0009986; C:cell surface
GO:0005737; C:cytoplasm
GO:0016021; C:integral to membrane
GO:0005886; C:plasma membrane
GO:0048185; F:activin binding
GO:0017002; F:activin-activated receptor activity
GO:0005524; F:ATP binding
GO:0019838; F:growth factor binding
GO:0046872; F:metal ion binding
GO:0004674; F:protein serine/threonine kinase activity
GO:0004712; F:protein serine/threonine/tyrosine kinase activity
GO:0004702; F:receptor signaling protein serine/threonine kinase activity
GO:0005024; F:transforming growth factor beta-activated receptor activity
GO:0032147; P:activation of protein kinase activity
GO:0009952; P:anterior/posterior pattern specification
GO:0060840; P:artery development
GO:0001974; P:blood vessel remodeling
GO:0030509; P:BMP signaling pathway
GO:0007368; P:determination of left/right symmetry
GO:0048617; P:embryonic foregut morphogenesis
GO:0001702; P:gastrulation with mouth forming second
GO:0007507; P:heart development
GO:0030073; P:insulin secretion
GO:0001822; P:kidney development
GO:0030324; P:lung development
GO:0001946; P:lymphangiogenesis
GO:0060836; P:lymphatic endothelial cell differentiation
GO:0007498; P:mesoderm development
GO:0042475; P:odontogenesis of dentin-containing tooth
GO:0035265; P:organ growth
GO:0060021; P:palate development
GO:0031016; P:pancreas development
GO:0032927; P:positive regulation of activin receptor signaling pathway
GO:0030501; P:positive regulation of bone mineralization
GO:0045669; P:positive regulation of osteoblast differentiation
GO:0009791; P:post-embryonic development
GO:0009966; P:regulation of signal transduction
GO:0009749; P:response to glucose stimulus
GO:0061298; P:retina vasculature development in camera-type eye
GO:0023014; P:signal transduction by phosphorylation
GO:0048705; P:skeletal system morphogenesis
GO:0060841; P:venous blood vessel development
KEGG
mmu:11481;
InterPros
IPR000333; Activin_II/TGFBeta-II_recpt.
IPR015768; Activin_II_recpt.
IPR000472; Activin_rcpt.
IPR011009; Kinase-like_dom.
IPR000719; Prot_kinase_cat_dom.
IPR008271; Ser/Thr_kinase_AS.
Pfam
PF01064; Activin_recp; 1.
PF00069; Pkinase; 1.
SMARTs
Prosites
PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00108; PROTEIN_KINASE_ST; 1.
Prints
PR00653; ACTIVIN2R.
Created Date20-Feb-2013